Treatments, options and pricing
Common Q&A about Private Human Metapneumovirus (HMP) Virus Testing
Our FAQ section is designed to address common questions you may have, from how our treatments work to what you can expect during and after your session.
Our team is always available to provide additional support if you need more personalised guidance, ensuring that you feel informed and confident every step of the way.
Human Metapneumovirus (HMP) is a respiratory virus that commonly causes upper and lower respiratory tract infections, such as colds, bronchitis, and pneumonia. It affects people of all ages but is particularly severe in young children, older adults, and immunocompromised individuals.
HMPV spreads through respiratory droplets when an infected person coughs or sneezes. It can also spread by touching contaminated surfaces and then touching your face, mouth, or eyes.
Common symptoms include:
- Cough
- Runny or congested nose
- Sore throat
- Fever
- Shortness of breath In severe cases, it can lead to wheezing, bronchiolitis, or pneumonia.
High-risk groups include:
- Infants and young children
- Older adults (65 years and older)
- Individuals with underlying health conditions, such as asthma, COPD, or heart disease
- Immunocompromised individuals
HMP can be diagnosed using specific laboratory tests
- Nasopharyngeal swabs
- Throat swabs
- Bronchoalveolar lavage (in severe cases)
There is no specific antiviral treatment for HMP. Management focuses on supportive care, such as:
- Rest
- Hydration
- Fever reducers and pain relievers (e.g., acetaminophen or ibuprofen) Severe cases may require oxygen therapy or hospitalization.
There is no vaccine for HMP. Preventative measures include:
- Practicing good hand hygiene
- Avoiding close contact with sick individuals
- Disinfecting frequently-touched surfaces
- Wearing masks during respiratory illness outbreaks
Most infections last about 1-2 weeks. However, recovery may take longer in individuals with weakened immune systems or underlying health conditions.
Testing is recommended if someone experiences severe or prolonged respiratory symptoms, especially if they are in a high-risk group. Healthcare providers may also test during outbreaks to identify the cause of respiratory illnesses.